Health Technology · Pharmaceuticals: Major · NSE: MEDIORG · data 2026-10-09

Medicamen Organics Ltd.

Health check: Weak (0.7/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹23.35

Market cap

₹37 cr

P/E

—

P/B

—

ROE

-13.7%

ROCE

-15.0%

Debt / equity

0.5

Dividend yield

0.00%

1-year return

-31.3%

52-week high

₹38

52-week low

₹19.1

Operating margin

-20.5%

Growth

Revenue (last 12 months)	₹23 cr
Net profit (last 12 months)	₹-4 cr
Sales growth, 3 years (yearly)	0.7%
Profit growth, 3 years (yearly)	—

Similar companies

Vivimed Labs Limited (VIVIMEDLAB) · Mangalam Drugs & Organics Ltd. (MANGALAM) · Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM) · Medi-Caps Ltd. (MEDICAPQ) · Lasa Supergenerics Ltd. (LASA)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open MEDIORG in NSE Scanner →